Indie studio Rainy Night Creations releases a new trailer for its horror game Vaccine, which looks and plays like classic Resident Evil games from the 90s.
There are a number of exciting horror games set to release in 2017, including high profile titles like Outlast 2 and We Happy Few. In fact, there are so many promising horror titles set to launch this year that a few have slipped under the radar, including an interesting indie title called Vaccine, which seems to be heavily inspired by the classic PS1-era Resident Evil games.
Vaccine is a horror game that has come out of nowhere, due for release on February 21, 2017 for PC, PS4, and Xbox One, with a Wii U version planned for March. The game looks as though it plays almost exactly like a classic survival-horror game, and it even features visuals that mimic the look of 90s horror titles like the original Resident Evil. However, Vaccine sets itself apart from the classics that inspired it in a couple of different ways.
One major way Vaccine is looking to differentiate itself from Resident Evil is with its procedurally-generated environments. Whereas Resident Evil only had one mansion to explore, those that play Vaccine will be going into a completely new mansion every time they play. The goal of the game is to explore this mansion fast enough to find a vaccine to save an infected friend before the time runs out, which should add a healthy dose of intensity to the proceedings.
Another way Vaccine is different from Resident Evil is through its RPG elements. While players are constantly tackling new mansions with random layouts, they will make progress by earning XP that can be used to purchase new skill points for the game’s two playable characters. Having a timer may prove to be a controversial gameplay feature, but it seems like more fans will be willing to embrace an RPG-like leveling system, especially since other classic survival-horror titles have experimented with it in the past – such as Square Enix’s Parasite Eve.
Overall, Vaccine seems like an interesting concept, but there’s a chance its retro graphics could turn players off. The PS1-era look it is trying to emulate hasn’t aged as well as the 16-bit graphic art styles we see in many games that go for a retro look, and the result may be that players pass on Vaccine because of its “ugly” graphics.
Something else that’s questionable about the game is why it’s launching on the Wii U, but is apparently skipping the Nintendo Switch. After all, the Wii U is a dying platform, with Nintendo ending production of the console, and releasing its last first-party game for it, The Legend of Zelda: Breath of the Wild, in less than a month’s time. It seems like it would make more sense for the developers of Vaccine to bring the game to Nintendo Switch instead, but perhaps the rumors that Nintendo kept Switch dev kits from third-party developers is true, and the team simply didn’t have the opportunity create a version for the new console.
Whatever the case may be, Vaccine could very well defy expectations and deliver a quality survival-horror experience that features some new ideas while also appealing to those nostalgic for classic Resident Evil. With the game set to launch in less than two weeks, horror fans won’t have to wait long to learn if Vaccine is worth their time.
Vaccine will be available on February 21st for PC, PS4, and Xbox One, with a Wii U version to follow in March.